ADMA Biologics Inc (ADMA)
19.04
-1.16
(-5.74%)
USD |
NASDAQ |
Nov 15, 16:00
19.01
-0.03
(-0.16%)
After-Hours: 20:00
ADMA Biologics Research and Development Expense (TTM): 1.868M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.868M |
| June 30, 2024 | 2.052M |
| March 31, 2024 | 2.895M |
| December 31, 2023 | 3.30M |
| September 30, 2023 | 3.929M |
| June 30, 2023 | 4.374M |
| March 31, 2023 | 3.845M |
| December 31, 2022 | 3.614M |
| September 30, 2022 | 3.268M |
| June 30, 2022 | 2.997M |
| March 31, 2022 | 3.282M |
| December 31, 2021 | 3.646M |
| September 30, 2021 | 3.930M |
| June 30, 2021 | 4.868M |
| March 31, 2021 | 5.366M |
| December 31, 2020 | 5.907M |
| September 30, 2020 | 5.358M |
| June 30, 2020 | 4.141M |
| March 31, 2020 | 3.002M |
| December 31, 2019 | 2.344M |
| September 30, 2019 | 2.796M |
| June 30, 2019 | 3.308M |
| March 31, 2019 | 3.831M |
| December 31, 2018 | 3.926M |
| Date | Value |
|---|---|
| September 30, 2018 | 4.214M |
| June 30, 2018 | 5.025M |
| March 31, 2018 | 5.343M |
| December 31, 2017 | 5.57M |
| September 30, 2017 | 4.949M |
| June 30, 2017 | 4.812M |
| March 31, 2017 | 6.853M |
| December 31, 2016 | 7.688M |
| September 30, 2016 | 9.102M |
| June 30, 2016 | 9.536M |
| March 31, 2016 | 7.642M |
| December 31, 2015 | 7.016M |
| September 30, 2015 | 6.939M |
| June 30, 2015 | 6.310M |
| March 31, 2015 | 6.588M |
| December 31, 2014 | 9.517M |
| September 30, 2014 | 10.55M |
| June 30, 2014 | 10.48M |
| March 31, 2014 | 12.17M |
| December 31, 2013 | 9.303M |
| September 30, 2013 | 7.615M |
| June 30, 2013 | 8.146M |
| March 31, 2013 | 4.855M |
| December 31, 2012 | 3.469M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
1.868M
Minimum
Sep 2024
5.907M
Maximum
Dec 2020
3.699M
Average
3.63M
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics Inc | 231.29M |
| Madrigal Pharmaceuticals Inc | 281.71M |
| Assembly Biosciences Inc | 49.97M |
| TG Therapeutics Inc | 87.86M |
| Krystal Biotech Inc | 51.42M |